文献速递中毒与环境急症心脑血管急症

ToxIC登记中曲马多过量相关癫痫发作:易感因素与纳洛酮的作用

Seizures in tramadol overdoses reported in the ToxIC registry: predisposing factors and the role of naloxone.
PubMed 文献 · Clin Toxicol (Phila) · 2019-01-24
一句话结论ToxIC登记显示,单剂曲马多过量者癫痫发作率52.5%,亚裔及滥用/误用者风险更高,纳洛酮使用与癫痫发作无显著关联。

该研究检索ToxIC数据登记库2014年1月1日至2017年12月31日所有单剂曲马多摄入病例,共80例,其中42例(52.5%)出现癫痫发作。亚裔患者(OR=7.2,95%CI:1.9-27.3,p=.004)及滥用或误用曲马多者(OR=3.2,95%CI:1.2-8.3,p=.02)更易出现癫痫发作;表现为阿片类中毒综合征者癫痫发作风险显著降低(OR=0.12,95%CI:0.03-0.60)。以自伤为目的摄入及年龄与癫痫发作风险增加无关;纳洛酮使用与癫痫发作无显著关联(OR=0.30,95%CI 0.07-1.25)。结论认为,基于ToxIC登记数据,曲马多诱发癫痫在亚裔及滥用或误用者中更常见,未发现纳洛酮使用与癫痫发作之间的关联。

要点

  • 单剂曲马多摄入80例中42例(52.5%)出现癫痫发作。
  • 亚裔患者癫痫发作风险更高(OR=7.2,95%CI:1.9-27.3,p=.004)。
  • 滥用或误用曲马多者癫痫发作风险更高(OR=3.2,95%CI:1.2-8.3,p=.02)。
  • 表现为阿片类中毒综合征者癫痫发作风险显著降低(OR=0.12,95%CI:0.03-0.60)。
  • 纳洛酮使用与癫痫发作无显著关联(OR=0.30,95%CI 0.07-1.25)。

适用人群与场景

  • ToxIC数据登记库中2014年1月1日至2017年12月31日所有单剂曲马多摄入病例。

研究设计与关键结果

  • 研究类型为基于ToxIC数据登记库的登记研究,共纳入80例单剂曲马多摄入病例,其中42例(52.5%)出现癫痫发作。
  • 亚裔患者较其他患者更易出现癫痫发作(OR=7.2,95%CI:1.9-27.3,p=.004)。
  • 滥用或误用曲马多者较非滥用/误用者更易出现癫痫发作(OR=3.2,95%CI:1.2-8.3,p=.02)。
  • 表现为阿片类中毒综合征者癫痫发作风险显著降低(OR=0.12,95%CI:0.03-0.60)。
  • 以自伤为目的摄入曲马多及年龄与癫痫发作风险增加无关。
  • 纳洛酮使用与癫痫发作无显著关联(OR=0.30,95%CI 0.07-1.25)。

证据类型、等级与局限

  • 证据类型:基于ToxIC数据登记库的登记研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,基于ToxIC登记数据,曲马多诱发癫痫在亚裔患者及滥用或误用曲马多者中更可能发生。
  • 作者认为,未发现纳洛酮使用与癫痫发作之间的关联。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Importance: Tramadol prescriptions have increased as fewer schedule II and III drugs are prescribed. There has been a concomitant increase in overdoses and adverse events recorded in the National Poison Data System. Seizure activity after tramadol overdose or therapeutic use is a well-documented adverse event. The primary objective is to evaluate the characteristics associated with seizures following single agent tramadol ingestion. Secondarily we aim to compare the rate of seizures in individuals treated, and not treated, with naloxone. Methods: We searched the Toxicology Investigators Consortium data registry for all cases of single agent tramadol ingestions from 01/01/2014 through 12/31/2017. Descriptive statistics were used to evaluate characteristics associated with increased risk of seizures. Binary logistic regressions were used to evaluate the associations between seizures and age, race, acuity, intent, toxidromes, symptoms, and treatments. Results: There were 80 single ingestion tramadol cases entered into the registry. Seizures developed in 42 (52.5%) patients. Asian patients (OR = 7.2, 95% CI: 1.9-27.3, p = .004) and patients abusing or misusing tramadol (OR = 3.2, 95% CI: 1.2-8.3, p = .02) more likely to develop seizures. Patients exhibiting an opioid toxidrome were significantly less likely to develop seizures (OR = 0.12, 95% CI: 0.03-0.60). Ingestion of tramadol as a means of self-harm and age were not associated with an increased risk of seizures. There was no significant association between naloxone administration and seizures (OR = 0.30, 95% CI 0.07-1.25). Conclusions: Based on data from the ToxIC registry, tramadol induced seizures are more likely in Asian patients and those abusing or misusing the medication. There was no association found between the development of seizures and the use of naloxone.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Murray BP, Carpenter JE, Dunkley CA, et al. Seizures in tramadol overdoses reported in the ToxIC registry: predisposing factors and the role of naloxone. Clin Toxicol (Phila). 2019. PMID: 30676832. doi:10.1080/15563650.2018.1547826

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。